|
|
|
|
|
|
|
|
abstract
Purpose:
Concerns about patient safety and the potential for
medical error are largely unexplored for genetic testing, despite the
expansion of test use. In this preliminary qualitative study, we sought
the views of genetics professionals about error and patient safety
concerns in genomic medicine and factors that might mitigate them.
Methods:
Twelve semistructured interviews with experienced genetics professionals were conducted. Transcripts were analyzed using selective coding for issues related to error definition, mitigation, and communication. Additional thematic analysis captured themes across content categories.Results:
Key informants suggested that the potential for adverse
events exists in all phases of genetic testing, from ordering to
analysis, interpretation, and follow-up. A perceived contributor was
lack of physician knowledge about genetics, resulting in errors in test
ordering and interpretation. The limitations and uncertainty inherent to
rapidly evolving technology were also seen as contributing factors.
Strategies to prevent errors included physician education, availability
of genetic experts for consultation, and enhanced communication such as
improved test reports and electronic decision support.
Conclusion:
Genetic testing poses concerns for patient safety due to
errors and the limitations of current tests. As genomic tests are
integrated into medical care, anticipating and addressing patient safety
concerns identified by these key informants will be crucial.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.